ChemPartner Launches Comprehensive Biology Database to Advance Drug Discovery
ChemPartner Biology Database ● Screenshot of the online Biology Database from ChemPartner ● Photo Credit: ChemPartner
SHANGHAI, China, December 22, 2023 (VSNewsNetwork.com) - ChemPartner, a drug discovery and development service provider, has announced the release of its highly anticipated Biology Database, according to a recent press release. This platform is designed to provide extensive access to a wide array of preclinical data, including over 800 tumor models and detailed information on more than 30 cancer types, among other significant data points.
Pie chart of cell line models available on the Biology Database from ChemPartner (Photo Credit: ChemPartner)
The database is part of ChemPartner's commitment to enhancing the efficiency and efficacy of the drug development process. It centralizes an immense collection of data meticulously curated by the company's biology and pharmacology department, known for its expertise in oncology, immunology, CNS, and metabolic services. This includes data from 2,000 biochemistry assays, 800 cell lines, 500 patient-derived xenograft (PDX) models, 350 cell-derived xenograft (CDX) models, and 50 syngeneic models, all characterized with comprehensive genomics, pharmacology, histopathology, and clinical information.
Dr. Lilly Xu, President of Shanghai ChemPartner, expressed the company's enthusiasm for the new resource, stating, “We are excited to provide our customers with access to this powerful new resource. This comprehensive database will make it easier for our customers to find and use the right models for their research, propelling drug development towards new heights with better precision, efficacy, and efficiency.”
The Biology Database is set to roll out in stages, with cell line data already available at https://database.chempartner.com. Future stages will unveil additional data on CDX, syngeneic, and PDX models, followed by biochemistry data. The platform's features aim to streamline research by providing unified data hubs, detailed annotations, rapid search and filtering capabilities, data analysis and mining tools, and clear data visualization options.
ChemPartner's move to launch this extensive database reflects its ongoing dedication to innovation in drug development services. By providing access to such a comprehensive range of data, the company aims to support pharmaceutical and biotechnological industries in their quest to develop more effective and efficient therapies.
To learn more, visit www.chempartner.com.
Source: ChemPartner via Newswire
